4//SEC Filing
Ellison Mark Jason Heath 4
Accession 0001385508-20-000013
CIK 0001385508other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:09 PM ET
Size
7.7 KB
Accession
0001385508-20-000013
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2020-01-07+4,150→ 9,680 total(indirect: See Footnote (1)) - Award
Common Stock
2020-01-07+8,250→ 8,250 totalExercise: $13.60Exp: 2030-01-07→ Common Stock (8,250 underlying)
Footnotes (2)
- [F1]4,150 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the RSUs vest on the anniversary dates of January 7, 2021, January 7, 2022, January 7, 2023 and January 7, 2024, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]On January 7, 2020, the reporting person was granted an option to purchase 8,250 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth year anniversary of the Grant Date.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001781982
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:09 PM ET
- Size
- 7.7 KB